Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross-species transmission of porcine endogenous retrovirus.

OBJECTIVE Acellularized porcine heart valve scaffolds have been successfully used for heart valve tissue engineering, creating living functioning heart valve tissue. However, there is concern about the possibility of porcine endogenous retrovirus transmission. In this study we investigated whether acellularized porcine heart valve scaffold causes cross-species transmission of porcine endogenous retrovirus in a sheep model. METHODS Acellularized porcine pulmonary valve conduits (n = 3) and in vitro autologous repopulated porcine pulmonary valve conduits (n = 5) were implanted into sheep in the pulmonary valve position. Surgery was carried out with cardiopulmonary bypass support. The animals were killed 6 months after the operation. Blood samples were collected regularly up to 6 months after the operation and tested for porcine endogenous retrovirus by means of polymerase chain reaction and reverse transcriptase-polymerase chain reaction. In addition, explanted tissue-engineered heart valves were tested for porcine endogenous retrovirus after 6 month in vivo. RESULTS Porcine endogenous retrovirus DNA was detectable in acellularized porcine heart valve tissue. However, 6 months after implantation of in vitro and in vivo repopulated acellularized porcine heart valve scaffolds, no porcine endogenous retrovirus sequences were detectable in heart valve tissue and peripheral blood. CONCLUSION Acellularized porcine matrix scaffolds used for creation of tissue-engineered heart valves do not transmit porcine endogenous retrovirus.

[1]  H. Alexander,et al.  Development and characterization of tissue-engineered aortic valves. , 2001, Tissue engineering.

[2]  F J Schoen,et al.  Tissue-engineered valved conduits in the pulmonary circulation. , 2000, The Journal of thoracic and cardiovascular surgery.

[3]  A Haverich,et al.  Heart valves from pigs and the porcine endogenous retrovirus: experimental and clinical data to assess the probability of porcine endogenous retrovirus infection in human subjects. , 2001, The Journal of thoracic and cardiovascular surgery.

[4]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[5]  W. Heneine,et al.  No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts , 1998, The Lancet.

[6]  Timothy M. Rose,et al.  Type C Retrovirus Released from Porcine Primary Peripheral Blood Mononuclear Cells Infects Human Cells , 1998, Journal of Virology.

[7]  F J Schoen,et al.  Functional Living Trileaflet Heart Valves Grown In Vitro , 2000, Circulation.

[8]  Y. Takeuchi,et al.  Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV) , 2000, Xenotransplantation.

[9]  A Haverich,et al.  Tissue engineering of heart valves--human endothelial cell seeding of detergent acellularized porcine valves. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  R. Leyh,et al.  Artifiziell hergestellte Herzklappen mittels „tissue engineering “ auf der Basis einer azellularisierten xenogenen Matrix: ln-vivo Untersuchungen im Schafmodell , 2002 .

[11]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[12]  W. Heneine,et al.  Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. , 1999, Science.

[13]  H. Erickson,et al.  Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. , 1993, Journal of cell science.

[14]  Yasuhiro Takeuchi,et al.  Infection of human cells by an endogenous retrovirus of pigs , 1997, Nature Medicine.

[15]  Frederick J Schoen,et al.  Cardiovascular tissue engineering. , 2002, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[16]  A Haverich,et al.  Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits: In Vivo Restoration of Valve Tissue , 2000, Circulation.

[17]  C K Breuer,et al.  Tissue engineering heart valves: valve leaflet replacement study in a lamb model. , 1995, The Annals of thoracic surgery.

[18]  W. Konertz,et al.  Lack of calcification of tissue engineered heart valves in juvenile sheep. , 2001, Seminars in thoracic and cardiovascular surgery.

[19]  D. Cheresh,et al.  Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells , 1989, Cell.

[20]  L. E. Curtis,et al.  Heart surgery--legend and a long look. , 1967, The American journal of cardiology.

[21]  R. Weiss.  Transgenic pigs and virus adaptation , 1998, Nature.